Copyright Reports & Markets. All rights reserved.

Global Chimeric Antigen Receptor Cell Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monotherapy
      • 1.4.3 Combination Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2014-2025)
      • 1.5.2 Acute Leukemia
      • 1.5.3 Non-hodgkin's Lymphoma
      • 1.5.4 Multiple Myeloma
      • 1.5.5 Transplant Rejection
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Chimeric Antigen Receptor Cell Therapy Market Size
    • 2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions
      • 2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Chimeric Antigen Receptor Cell Therapy Market Size by by Players
      • 3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
    • 3.3 Key Players Chimeric Antigen Receptor Cell Therapy Product/Solution/Service
    • 3.4 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2014-2019)
    • 4.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 5.2 Chimeric Antigen Receptor Cell Therapy Key Players in United States
    • 5.3 United States Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 5.4 United States Chimeric Antigen Receptor Cell Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 6.2 Chimeric Antigen Receptor Cell Therapy Key Players in Europe
    • 6.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 6.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application

    7 China

    • 7.1 China Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 7.2 Chimeric Antigen Receptor Cell Therapy Key Players in China
    • 7.3 China Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 7.4 China Chimeric Antigen Receptor Cell Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 8.2 Chimeric Antigen Receptor Cell Therapy Key Players in Japan
    • 8.3 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 8.4 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 9.2 Chimeric Antigen Receptor Cell Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 9.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application

    10 India

    • 10.1 India Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 10.2 Chimeric Antigen Receptor Cell Therapy Key Players in India
    • 10.3 India Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 10.4 India Chimeric Antigen Receptor Cell Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
    • 11.2 Chimeric Antigen Receptor Cell Therapy Key Players in Central & South America
    • 11.3 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type
    • 11.4 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen Inc
      • 12.1.1 Amgen Inc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.1.5 Amgen Inc Recent Development
    • 12.2 Autolus Therapeutics Plc
      • 12.2.1 Autolus Therapeutics Plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.2.5 Autolus Therapeutics Plc Recent Development
    • 12.3 Beijing Immunochina Medical Science & Technology Co Ltd
      • 12.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
    • 12.4 Bellicum Pharmaceuticals Inc
      • 12.4.1 Bellicum Pharmaceuticals Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.4.5 Bellicum Pharmaceuticals Inc Recent Development
    • 12.5 Bristol-Myers Squibb Co
      • 12.5.1 Bristol-Myers Squibb Co Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.5.5 Bristol-Myers Squibb Co Recent Development
    • 12.6 bluebird bio Inc
      • 12.6.1 bluebird bio Inc Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.6.5 bluebird bio Inc Recent Development
    • 12.7 CARsgen Therapeutics Ltd
      • 12.7.1 CARsgen Therapeutics Ltd Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.7.5 CARsgen Therapeutics Ltd Recent Development
    • 12.8 Celgene Corp
      • 12.8.1 Celgene Corp Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.8.5 Celgene Corp Recent Development
    • 12.9 Cell Medica Ltd
      • 12.9.1 Cell Medica Ltd Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.9.5 Cell Medica Ltd Recent Development
    • 12.10 Cellular Biomedicine Group Inc
      • 12.10.1 Cellular Biomedicine Group Inc Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Chimeric Antigen Receptor Cell Therapy Introduction
      • 12.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
      • 12.10.5 Cellular Biomedicine Group Inc Recent Development
    • 12.11 Celularity Inc
    • 12.12 Celyad SA
    • 12.13 Daiichi Sankyo Co Ltd
    • 12.14 Fosun Pharmaceutical AG
    • 12.15 Gilead Sciences Inc
    • 12.16 Guangzhou Anjie Biomedical Technology Co Ltd
    • 12.17 Hangzhou Converd Co Ltd
    • 12.18 Hebei Senlang Biotechnology Inc Ltd
    • 12.19 HRAIN Biotechnology Co Ltd
    • 12.20 Juno Therapeutics Inc
    • 12.21 Kite Pharma Inc
    • 12.22 Nanjing Legend Biotech Co Ltd
    • 12.23 NantKwest Inc
    • 12.24 Nkarta Inc
    • 12.25 Novartis AG
    • 12.26 Ono Pharmaceutical Co Ltd
    • 12.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
    • 12.28 Sorrento Therapeutics Inc
    • 12.29 Takara Bio Inc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Chimeric Antigen Receptor Cell Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Chimeric Antigen Receptor Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chimeric Antigen Receptor Cell Therapy development in United States, Europe and China.

      The key players covered in this study
      Amgen Inc
      Autolus Therapeutics Plc
      Beijing Immunochina Medical Science & Technology Co Ltd
      Bellicum Pharmaceuticals Inc
      Bristol-Myers Squibb Co
      bluebird bio Inc
      CARsgen Therapeutics Ltd
      Celgene Corp
      Cell Medica Ltd
      Cellular Biomedicine Group Inc
      Celularity Inc
      Celyad SA
      Daiichi Sankyo Co Ltd
      Fosun Pharmaceutical AG
      Gilead Sciences Inc
      Guangzhou Anjie Biomedical Technology Co Ltd
      Hangzhou Converd Co Ltd
      Hebei Senlang Biotechnology Inc Ltd
      HRAIN Biotechnology Co Ltd
      Juno Therapeutics Inc
      Kite Pharma Inc
      Nanjing Legend Biotech Co Ltd
      NantKwest Inc
      Nkarta Inc
      Novartis AG
      Ono Pharmaceutical Co Ltd
      Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
      Sorrento Therapeutics Inc
      Takara Bio Inc

      Market segment by Type, the product can be split into
      Monotherapy
      Combination Therapy

      Market segment by Application, split into
      Acute Leukemia
      Non-hodgkin's Lymphoma
      Multiple Myeloma
      Transplant Rejection
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Chimeric Antigen Receptor Cell Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Chimeric Antigen Receptor Cell Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Chimeric Antigen Receptor Cell Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now